MAP3K11 and ovarian cancer: We observed a significant reduction in the percentage of p-Histone H3–positive cells in SKOV3 cells treated with URMC099 but not in T80 cells (Fig. 5A), suggesting that MLK3 might play an essential role in ovarian cancer cell cycle progression.